BethesdaA model projects science losses through 2050.
Trainees cut today vanish as missing labs fifteen years later.
A 40% cut would drop principal investigators 50% within nine years, the model found, before a partial rebound.
Novel drug approvals could fall 44% below baseline by 2050 under the cut scenario.
Sources: Nature